The US Food and Drug Administration (FDA) has expanded the indication for the Sapien 3 transcatheter heart valve (Edwards Lifesciences) to include valve-in-valve replacement for high-risk patients ...
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach ...
Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the company said Monday. The device is designed for people with symptomatic mitral ...
Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...
(RTTNews) - Edwards Lifesciences Corp. (EW) on Tuesday said its SAPIEN M3 mitral valve replacement system received U.S. Food and Drug Administration (FDA) approval for the treatment of mitral ...
WASHINGTON -- A slight tweak to the Sapien 3 turned it into a device usable for transcatheter mitral valve replacement (TMVR), a first-in-human experience showed. By adding a new sealing skirt, ...
Edwards Lifesciences said Wednesday its transcatheter aortic valve replacement (TAVR) device is similarly effective in patients with small and large aortic annuli. Earlier this year, Medtronic linked ...
The FDA today approved an expanded indication for Edwards Lifesciences' Sapien transcatheter heart valve (THV). The device can now be implanted in patients who are eligible for aortic valve ...
The FDA has approved Edwards Lifesciences Corp.’s Sapien M3 transcatheter mitral valve replacement system. The U.S. approval, announced last week, comes eight months after the device received CE Mark ...
Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences Corporation announced that it has received CE Mark in Europe for valve-in-valve procedures ...
After much anticipation and drama, the FDA has approved the Sapien transcatheter aortic heart valve. The news was announced late Wednesday afternoon by the FDA and by Edwards Lifesciences, the ...
Japan granted an insurance reimbursement for the Sapien XT valve.--Courtesy of Edwards Lifesciences Edwards Lifesciences' ($EW) Sapien heart-valve revenue engine gets ...